Safety and efficacy of a feed additive consisting of viable cells of Lactobacillus acidophilusCNCM I-3231, Ligilactobacillus salivariusCNCM I-3233, Lactiplantibacillus plantarumCNCM I-3232, Lacticaseibacillus rhamnosusCNCM I-4427, and Bifidobacterium animalis subsp. lactis CNCM I-3993 (FlorEquilibre® Chien) for dogs (Wamine SAS).
- 2025-12
- EFSA journal. European Food Safety Authority 23(12)
- Roberto Edoardo Villa
- Giovanna Azimonti
- Eleftherios Bonos
- Henrik Christensen
- Mojca Durjava
- Birgit Dusemund
- Ronette Gehring
- Boet Glandorf
- Maryline Kouba
- Marta López-Alonso
- Francesca Marcon
- Carlo Nebbia
- Alena Pechová
- Miguel Prieto-Maradona
- Ilen Röhe
- Katerina Theodoridou
- Giovanna Martelli
- Baltasar Mayo
- Maria Saarela
- Montserrat Anguita
- Nicole Bozzi Cionci
- Rosella Brozzi
- Matteo L Innocenti
- Jordi Ortuño
- PubMed: 41377166
- DOI: 10.2903/j.efsa.2025.9794
Study Design
- Type
- Review
- Population
- dogs
- Methods
- EFSA scientific opinion on the safety and efficacy of FlorEquilibre® Chien when used as a zootechnical additive (functional group: gut flora stabilisers)
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety and efficacy of FlorEquilibre® Chien when used as a zootechnical additive (functional group: gut flora stabilisers) for dogs. The product under assessment is based on viable cells of Lactobacillus acidophilus CNCM I-3231, Ligilactobacillus salivarius CNCM I-3233, Lactiplantibacillus plantarum CNCM I-3232, Lacticaseibacillus rhamnosus CNCM I-4427 and Bifidobacterium animalis subsp. lactis CNCM I-3993. L. acidophilus CNCM I-3231, L. salivarius CNCM I-3233, L. plantarum CNCM I-3232 and L. rhamnosus CNCM I-4427 are considered by EFSA to be suitable for the qualified presumption of safety approach. The identity of these strains was established, and no acquired antimicrobial resistance genes were detected. Therefore, the FEEDAP Panel concluded that the use of these four strains is presumed safe for the target species and the environment. However, the Panel notes that the use of B. animalis subsp. lactis CNCM I-3993 represents a safety concern for the target species, the users and the environment because the strain harbours an acquired antimicrobial resistance gene. The Panel concluded that the additive is eye irritant, and a skin and respiratory sensitiser. Exposure via any route is considered a risk. Based on the data provided, the Panel is not in the position to conclude on the efficacy of the additive for dogs.
Research Insights
| Supplement | Dose | Health Outcome | Effect Type | Effect Size | Source |
|---|---|---|---|---|---|
| Bifidobacterium plantarum | — | No Conclusive Efficacy | Neutral | Small | View sourceBased on the data provided, the Panel is not in the position to conclude on the efficacy of the additive for dogs. |
| Bifidobacterium plantarum | — | Safety Concern in Target Species | Harmful | Moderate | View sourcethe Panel notes that the use of B. animalis subsp. lactis CNCM I-3993 represents a safety concern for the target species, the users and the environment because the strain harbours an acquired antimicrobial resistance gene. |